YIL054W is a yeast open reading frame (ORF) with limited functional annotation in public databases. Proteins encoded by ORFs like YIL054W are often studied for their roles in cellular processes such as metabolism, DNA repair, or stress response. The UniProt entry (P40524) classifies it as an uncharacterized protein, highlighting the need for further research .
While specific validation data for YIL054W Antibody is not publicly disclosed, best practices in antibody validation—as outlined by initiatives like YCharOS—require:
Knockout (KO) validation: Confirming antibody specificity using yeast strains lacking the YIL054W gene .
Orthogonal methods: Cross-verification with mass spectrometry or transcriptomics .
Application-specific testing: Ensuring performance in WB, IF, or IP .
Commercial antibodies often lack transparent validation data, which underscores the importance of independent verification by researchers .
The YIL054W Antibody is primarily used to:
Localize the YIL054W protein in yeast cells via immunofluorescence .
Detect protein expression levels under varying conditions (e.g., stress, genetic perturbations) .
Study protein-protein interactions through co-immunoprecipitation .
The Cusabio catalog includes multiple antibodies targeting yeast proteins, such as:
| Antibody Code | Target Protein | UniProt ID | Applications |
|---|---|---|---|
| CSB-PA340267XA01SVG | YIL054W | P40524 | WB, IF, IP |
| CSB-PA315788XA01SVG | TY1A-LR1 | P0CX68 | WB, IF |
| CSB-PA236711XA01SVG | YLR271W | Q06152 | WB |
This diversity enables researchers to study yeast proteomics systematically .
Specificity Concerns: Homology between yeast proteins may lead to off-target binding. For example, X-chromosome gametologs in humans show cross-reactivity issues .
Validation Gaps: Only 20–50% of commercial antibodies meet validation standards for stated applications .
Best Practices:
Projects like YCharOS aim to characterize antibodies proteome-wide, including yeast targets. Integration with databases such as YAbS (The Antibody Society’s database) could enhance transparency in antibody performance .
KEGG: sce:YIL054W
STRING: 4932.YIL054W
YIL054W refers to an uncharacterized membrane protein in Saccharomyces cerevisiae. The "YIL054W" designation follows the systematic naming convention for yeast genes, where "Y" indicates yeast origin, "IL" refers to its chromosomal location, "054" is its relative position on the chromosome, and "W" indicates it's transcribed from the Watson (forward) strand . Although currently uncharacterized, this membrane protein represents one of many proteins in yeast whose functions remain to be elucidated through systematic study. Antibodies against YIL054W provide researchers with a specific tool to track this protein in various experimental contexts despite limited knowledge about its function .
The primary research applications for YIL054W antibodies include studying expression patterns under different conditions, investigating subcellular localization, identifying potential protein-protein interactions, and examining possible roles in cellular processes. These antibodies enable researchers to bridge the gap between genomic information (the YIL054W open reading frame) and functional characterization at the protein level .
Based on the available literature, the primary type of YIL054W antibody documented for research use is rabbit polyclonal antibody against Saccharomyces cerevisiae (strain 204508/S288c) YIL054W . These antibodies are generated by immunizing rabbits with YIL054W-specific antigens, producing a mixture of antibodies that recognize different epitopes on the target protein. The antibodies are typically purified using antigen-affinity methods to ensure specificity against the target protein .
The available polyclonal YIL054W antibodies have been validated for specific applications including Enzyme-Linked Immunosorbent Assay (ELISA) and Western blot analysis . These applications allow researchers to detect and quantify YIL054W in different experimental contexts, making them valuable tools for studying this uncharacterized membrane protein. The isotype of these antibodies is reported as IgG, which is the predominant antibody class used in research applications .
YIL054W antibodies are employed in several key research applications for studying this uncharacterized yeast membrane protein:
Western Blotting (WB): This application enables researchers to detect and quantify YIL054W protein expression in yeast cell lysates, providing insights into expression levels under different experimental conditions . Western blotting with YIL054W antibodies allows for size verification and relative quantification of the protein.
Enzyme-Linked Immunosorbent Assay (ELISA): This technique provides a quantitative method for detecting YIL054W in solution with high sensitivity . ELISA applications allow researchers to measure protein levels in different samples and compare expression across conditions.
Immunoprecipitation (IP): Although not explicitly mentioned in the search results for YIL054W specifically, antibodies against yeast proteins are commonly used to isolate the target protein along with its binding partners from cell lysates . This application is particularly valuable for studying protein-protein interactions and complexes.
Chromatin Immunoprecipitation (ChIP): For proteins that associate with chromatin, ChIP assays using specific antibodies can help determine DNA binding sites . While the search results don't directly confirm YIL054W's association with chromatin, this technique could potentially be applied if such interactions exist.
Immunofluorescence: This application would be particularly relevant for studying the subcellular localization of membrane proteins like YIL054W, providing visual evidence of where the protein resides within yeast cells.
When designing experiments with YIL054W antibodies, a systematic approach is essential for generating reliable and interpretable results:
1. Experimental Planning:
Define clear research questions about YIL054W (expression pattern, localization, interactions)
Select appropriate techniques based on your question (Western blot, IP, immunofluorescence)
Include proper controls (see section 2.2)
Design time courses or condition comparisons to capture dynamic changes
2. Sample Preparation for Membrane Proteins:
For membrane proteins like YIL054W, use appropriate extraction methods:
Detergent-based lysis buffers (e.g., containing 0.5-1% NP-40, Triton X-100)
Consider specialized membrane protein extraction kits
Optimize lysis conditions to maintain protein integrity while ensuring extraction
When preparing samples for Western blot analysis, consider using NuPAGE gels as mentioned in the literature for effective separation of yeast proteins
3. Experimental Protocol Design:
For Western blots:
Determine optimal antibody concentration through titration experiments
Select appropriate blocking agents (typically 5% nonfat dry milk as mentioned in the literature)
Establish suitable incubation times and washing protocols
Use nitrocellulose membranes for protein transfer as documented in successful protocols
4. Data Analysis Approach:
Plan quantification methods before beginning experiments
Determine statistical analyses appropriate for your experimental design
Include biological replicates (minimum n=3) for statistical validity
Consider how to normalize data (loading controls, housekeeping proteins)
5. Validation Strategy:
Plan secondary validation using orthogonal methods
Consider genetic approaches (gene deletion/overexpression) to complement antibody studies
Include positive controls with known expression patterns or interactions
When conducting experiments with YIL054W antibodies, implementing proper controls is essential for accurate interpretation of results:
Essential Controls for YIL054W Antibody Experiments:
Negative Controls:
Lysate from YIL054W deletion strain (ΔYIL054W): Should show no signal, confirming antibody specificity
Primary antibody omission: To assess background signal from secondary antibody alone
Isotype control: Use non-specific rabbit IgG at the same concentration as the YIL054W antibody
Pre-immune serum (for polyclonal antibodies): To establish baseline reactivity before immunization
Positive Controls:
Loading Controls:
For Western blotting: Include antibodies against housekeeping proteins (e.g., actin)
For membrane proteins specifically: Consider membrane protein loading controls
Specificity Controls:
Peptide competition assay: Pre-incubation of antibody with the immunizing peptide should block specific binding
Multiple antibodies: If available, use different antibodies recognizing distinct epitopes
Cross-reactivity Controls:
Test reactivity in other yeast species if studying evolutionary conservation
Assess potential cross-reactivity with related proteins
Validating antibody specificity is crucial, especially for uncharacterized proteins like YIL054W where limited prior knowledge exists:
Comprehensive Validation Strategy:
Genetic Validation:
Compare signal between wild-type and ΔYIL054W knockout strains
Test antibody in strains with epitope-tagged YIL054W (confirms identity)
Examine signal in strains with regulated expression (e.g., using GAL1 promoter)
Biochemical Validation:
Peptide Competition Assay: Pre-incubate antibody with immunizing peptide/protein; specific signal should disappear
Immunoprecipitation-Mass Spectrometry: IP followed by MS should identify YIL054W as a major hit
Size Verification: Signal should appear at the predicted molecular weight (accounting for potential post-translational modifications)
Orthogonal Methods:
Compare antibody results with tagged version detection
Validate localization using fluorescently-tagged YIL054W compared to immunofluorescence
Correlate protein detection with mRNA levels (though imperfect, should show some correlation)
Specificity Testing Table:
| Validation Method | Expected Outcome | Interpretation If Failed |
|---|---|---|
| Western blot in WT vs. ΔYIL054W | Signal in WT, none in deletion | Antibody likely non-specific |
| Peptide competition | Decreased/absent signal | Binding may be specific but to wrong target |
| IP-MS | YIL054W identified as major hit | May be recognizing wrong protein |
| Size verification | Band at predicted MW | May be specific to a different protein |
| Correlation with mRNA levels | General correlation under varying conditions | May have technical issues or complex protein regulation |
Documentation:
Record all validation experiments in detail
Include validation data in publications
Note any limitations discovered during validation
YIL054W antibodies can serve as powerful tools for discovering novel protein complexes and interactions, following approaches documented for other yeast proteins:
Methodological Approach to Complex Identification:
Immunoaffinity Purification for Complex Isolation:
Following approaches similar to those described for other yeast proteins :
Couple anti-YIL054W antibodies to protein A-Sepharose beads
Prepare native cell lysates using gentle detergents
Incubate lysates with antibody-coupled beads (overnight at 4°C)
Wash thoroughly to remove non-specific binders (typically four washes)
Elute bound proteins using appropriate methods
Mass Spectrometry Analysis of Co-purified Proteins:
Verification of Interactions:
Perform reciprocal immunoprecipitation with antibodies against identified partners
Conduct co-localization studies using fluorescently tagged proteins
Implement functional assays to test biological relevance of interactions
Network Analysis:
Integrate identified interactions with existing protein interaction databases
Apply bioinformatic approaches to predict functional modules and pathways
Example Protocol for Complex Identification:
Prepare yeast cell lysate in buffer containing 20 mM HEPES (pH 7.9), 0.5% NP-40, and protease inhibitors
Couple 20 μg of purified anti-YIL054W antibody to 10 μl protein A-Sepharose beads
Incubate lysate with antibody-coupled beads overnight at 4°C
Wash beads 4 times with washing buffer
Elute bound proteins and analyze by SDS-PAGE followed by mass spectrometry
Compare results with control IPs using non-specific IgG
For an uncharacterized membrane protein like YIL054W, determining subcellular localization is crucial for understanding its function:
Advanced Localization Approaches:
Immunofluorescence Microscopy:
Fix yeast cells with formaldehyde and digest cell wall with zymolyase
Permeabilize with detergent appropriate for membrane proteins
Incubate with anti-YIL054W antibody followed by fluorescent secondary antibody
Co-stain with organelle markers (e.g., DAPI for nucleus, mitochondrial markers)
Immuno-Electron Microscopy:
For high-resolution localization of membrane proteins
Use gold-conjugated secondary antibodies
Allows visualization of precise membrane domain localization
Biochemical Fractionation with Immunoblotting:
Separate cellular components (cytosol, nuclei, mitochondria, ER, etc.)
Perform Western blotting on each fraction using anti-YIL054W antibody
Include marker proteins for each compartment as controls
Proximity Labeling Combined with Immunoprecipitation:
Express BioID or APEX2 fusion with YIL054W
After proximity labeling, use anti-YIL054W antibodies to confirm expression
Compare biotinylated proteins with known organelle markers
Live-Cell Imaging Validation:
Compare antibody-based localization with fluorescently-tagged YIL054W
Use antibodies to validate that tagged version localizes similarly to endogenous protein
Integration Matrix for Localization Data:
| Technique | Resolution | Advantages | Limitations | Complementary Methods |
|---|---|---|---|---|
| Immunofluorescence | ~200 nm | Works on fixed cells, multiple markers | Lower resolution | Super-resolution microscopy |
| Immuno-EM | ~10 nm | Highest resolution | Complex sample prep, less conducive to multiple labeling | Correlative light-EM |
| Biochemical fractionation | N/A (biochemical) | Quantitative, scalable | Potential cross-contamination | Mass spec of fractions |
| Proximity labeling | Depends on fusion | Works in living cells | Requires genetic modification | IP-MS validation |
YIL054W antibodies provide valuable tools for systematically characterizing an unknown membrane protein through multiple experimental approaches:
Systematic Characterization Framework:
Expression Analysis Under Different Conditions:
Use anti-YIL054W antibodies in Western blots to quantify expression changes:
Different growth phases
Various stress conditions
Nutrient limitations
Genetic backgrounds (deletion of candidate regulatory factors)
Create expression profile correlations with known pathways
Topology Determination:
Combined with protease protection assays to determine membrane orientation
Differential permeabilization immunofluorescence to map epitope accessibility
Compare with in silico topology predictions
Post-translational Modification Identification:
Immunoprecipitate YIL054W and analyze by mass spectrometry
Use phospho-specific or glyco-specific detection methods after IP
Compare migration patterns under different conditions
Functional Association Studies:
Correlate protein presence/absence with phenotypic assays
Use antibodies to test for co-localization with proteins of known function
Apply to samples after various cellular perturbations
Evolutionary Conservation Analysis:
Test cross-reactivity with homologs in related yeast species
Compare localization patterns across species
Integrate with comparative genomics data
Researchers working with antibodies against uncharacterized membrane proteins like YIL054W often encounter specific challenges that require systematic troubleshooting:
Common Issues and Solutions:
Weak or No Signal in Western Blot:
Potential Causes:
Insufficient protein extraction (common with membrane proteins)
Low expression level of YIL054W
Epitope masking or denaturation
Solutions:
Use specialized membrane protein extraction buffers containing appropriate detergents
Increase protein loading amount (up to 100 μg per lane)
Try different blotting membranes (PVDF may retain membrane proteins better than nitrocellulose)
Optimize transfer conditions (lower voltage for longer time)
Try both reducing and non-reducing conditions
Enhance detection with high-sensitivity substrates
Multiple Bands/Non-specific Binding:
Potential Causes:
Cross-reactivity of polyclonal antibody
Post-translational modifications
Protein degradation
Solutions:
Increase antibody dilution
Use more stringent washing conditions
Add 0.1-0.5% SDS to antibody dilution buffer
Use freshly prepared samples with additional protease inhibitors
Purify antibody by pre-adsorption against ΔYIL054W lysate
Inconsistent Results Across Experiments:
Potential Causes:
Variations in protein extraction efficiency
Antibody lot-to-lot variation
YIL054W expression fluctuations
Solutions:
Standardize growth conditions precisely
Use internal loading controls consistently
Prepare larger batches of antibody working dilution
Document antibody lot numbers and standardize protocols
Failed Immunoprecipitation:
Potential Causes:
Antibody may recognize denatured but not native protein
Epitope inaccessibility in native state
Insufficient antibody amount
Solutions:
Try different lysis buffers with varying detergent types/concentrations
Cross-link antibody to beads to prevent heavy chain contamination
Increase antibody:lysate ratio
Use tagged version as positive control
Optimizing immunoaffinity purification for membrane proteins like YIL054W requires careful consideration of multiple parameters:
Step-by-Step Optimization Protocol:
Antibody Coupling Optimization:
Test different coupling methods:
Direct coupling to Sepharose/agarose
Protein A/G bead binding
Magnetic beads for gentler handling
Optimize antibody amount (typically 2-20 μg per reaction)
Consider oriented coupling techniques for improved antigen recognition
Lysis Buffer Optimization:
For membrane proteins like YIL054W, test multiple detergent conditions:
Mild: 0.5-1% NP-40, Triton X-100
Moderate: CHAPS, Brij-35
Stronger: Digitonin, DDM for intact membrane complexes
Buffer components similar to those documented for other yeast proteins:
Binding Conditions:
Optimize time: 2 hours to overnight at 4°C
Test binding with rotation vs. gentle rocking
Consider adding stabilizing agents (glycerol, specific ions)
Washing Optimization:
Develop increasingly stringent wash steps:
Initial washes: Same as lysis buffer
Middle washes: Increased salt (150-300 mM)
Final washes: Reduced detergent, maintained salt
Elution Strategy Selection:
Peptide competition (gentlest, most specific)
pH shift (acidic glycine buffer, pH 2.5-3.0)
SDS elution (most complete but denaturing)
Optimization Matrix:
| Parameter | Starting Condition | Variables to Test | Evaluation Method |
|---|---|---|---|
| Antibody amount | 5 μg | 2, 5, 10, 20 μg | Western blot of eluted material |
| Detergent type | 0.5% NP-40 | NP-40, Triton X-100, Digitonin, CHAPS | Protein yield and complex integrity |
| Salt concentration | 150 mM NaCl | 100, 150, 250, 300 mM | Target:background ratio |
| Binding time | 4 hours | 2h, 4h, overnight | Yield comparison |
| Wash stringency | 4x base buffer | Increasing salt gradient, detergent reduction | Background reduction |
| Elution method | pH shift | pH shift, peptide, SDS | Yield and protein activity |
Optimizing detection methods for YIL054W requires adapting standard protocols to accommodate membrane protein characteristics:
Western Blot Best Practices:
Sample Preparation:
Use fresh yeast cultures for consistent expression
Optimize lysis buffer for membrane proteins:
Include 1-2% detergent (Triton X-100, NP-40, or specialized membrane detergents)
Consider glass bead disruption for yeast cells
Heat samples at 37°C instead of boiling to prevent membrane protein aggregation
Add reducing agent (DTT or β-mercaptoethanol) immediately before loading
Gel Electrophoresis:
Transfer Optimization:
For membrane proteins:
Use PVDF membrane (0.45 μm pore size)
Add 0.05-0.1% SDS to transfer buffer to aid elution from gel
Transfer at lower voltage (30V) overnight at 4°C
Consider semi-dry transfer systems for larger proteins
Antibody Incubation:
Detection Strategy:
For low abundance proteins, use high-sensitivity ECL substrates
Consider signal enhancement systems
Optimize exposure times (series of exposures from 10 sec to 10 min)
ELISA Best Practices:
Plate Preparation:
For membrane proteins, consider pre-coating with capture antibodies
Use high-binding plates designed for protein assays
Adequately block with BSA or specialized blocking buffers
Sample Preparation:
Optimize detergent concentration to solubilize YIL054W without interfering with antibody binding
Prepare standard curve using recombinant or purified YIL054W if available
Include sample dilution series to ensure measurements in linear range
Assay Protocol:
Extend incubation times to improve sensitivity (2h or overnight)
Maintain consistent temperature throughout procedure
Use multi-channel pipettes for timing consistency
Detection Optimization:
Choose substrate based on required sensitivity
Measure kinetic development to determine optimal read time
Include both positive and negative controls on each plate
Proper analysis of Western blot data for uncharacterized proteins requires rigorous quantification and interpretation approaches:
Comprehensive Analysis Framework:
Image Acquisition Considerations:
Capture multiple exposure times to ensure signal is within linear range
Use a digital system with sufficient dynamic range
Save images in uncompressed format with metadata preserved
Quantification Methodology:
Measure band intensity using appropriate software (ImageJ, Image Lab, etc.)
Subtract local background for each lane
Normalize to loading controls (housekeeping proteins)
For expression studies, calculate relative expression compared to baseline
Statistical Analysis:
For multiple experiments, calculate mean and standard deviation/SEM
Apply appropriate statistical tests for comparisons (t-test, ANOVA)
Consider non-parametric tests if sample size is small
Determine significance with appropriate p-value thresholds
Interpretation Guidelines:
For an uncharacterized protein like YIL054W:
Compare observed molecular weight to predicted size
Note any additional bands that might represent isoforms or modifications
Correlate expression patterns with experimental conditions
Integrate with other data types (localization, interactome)
Visualization Best Practices:
Present representative blots alongside quantification
Use consistent scaling for fair comparisons
Include all relevant controls in figures
Indicate molecular weight markers
When facing contradictory results with YIL054W antibodies, systematic troubleshooting and verification approaches are essential:
Resolution Framework for Contradictory Results:
Technical Verification:
Antibody Validation Revisited:
Test different lots of the same antibody
Try antibodies from different suppliers or targeting different epitopes
Perform epitope mapping to understand recognition sites
Protocol Standardization:
Document and control all variables in the experimental workflow
Implement detailed standard operating procedures for critical steps
Use positive controls consistently across experiments
Biological Context Exploration:
Expression Variability Assessment:
Test if YIL054W expression varies with:
Growth phase
Media composition
Strain background
Environmental conditions
Correlate protein detection with mRNA levels
Post-translational Modification Analysis:
Investigate if contradictory results reflect different modification states
Test with phosphatase treatment, deglycosylation enzymes, etc.
Use 2D gels to separate protein variants
Orthogonal Approach Integration:
Verify results with complementary methods:
Mass spectrometry identification
Genetic tagging (epitope tags, fluorescent proteins)
Functional assays correlated with expression
Use genetic approaches:
Create conditional expression strains
Use CRISPR/Cas9 for tagging endogenous locus
Contradictory Data Reconciliation Matrix:
| Contradiction Type | Investigation Approach | Expected Outcome | Interpretation |
|---|---|---|---|
| Signal in different locations | Subcellular fractionation + WB | Enrichment in specific fraction | Determines true localization |
| Variable expression levels | RT-qPCR + WB correlation | Correlation between mRNA and protein | Confirms expression variation is biological |
| Different molecular weights | 2D gels + WB | Separation of different forms | Identifies modifications or processing |
| Inconsistent interactions | IP under different conditions | Condition-dependent interactions | Reveals regulated interactions |
| Antibody specificity questions | IP-MS analysis | Identification of pulled-down proteins | Confirms actual targets |
Mass spectrometry provides powerful complementary approaches to antibody-based detection of uncharacterized proteins:
Integrated Mass Spectrometry Approaches:
Protein Identification and Validation:
Direct Analysis of Large Protein Complexes (DALPC) as described in published protocols :
Immunoprecipitate YIL054W using specific antibodies
Analyze by LC-MS/MS to confirm protein identity
Identify peptide coverage across the protein sequence
Verify antibody specificity by confirming target identity
Post-translational Modification Mapping:
Enrichment approaches:
Immunoprecipitate YIL054W with specific antibodies
Analyze for modifications using targeted MS approaches
Map modification sites to protein domains/motifs
Comparative approaches:
Compare modification profiles under different conditions
Correlate with functional changes
Interaction Network Analysis:
Hierarchical Clustering Analysis as described for other yeast proteins :
Identify proteins that consistently co-purify with YIL054W
Apply unbiased statistical clustering to determine interaction confidence
Compare with control purifications to eliminate false positives
Map YIL054W to protein complexes or pathways
Quantitative Expression Analysis:
Label-free quantification:
Compare YIL054W peptide abundance across samples
Correlate with antibody-based quantification
Labeled approaches (SILAC, TMT):
Provide precise relative quantification
Enable multiplexed comparison across conditions
Membrane Topology Analysis:
Surface accessibility methods:
Combine limited proteolysis with MS to map exposed regions
Compare with antibody epitope accessibility
Cross-linking approaches:
Identify neighboring proteins and proximities
Validate antibody-based co-localization findings